Pharmacogenomic testing for Prader-Willi syndrome: a mixed methods analysis of caregiver experiences and utilization
PGx results are perceived as valuable to the PWS population, but sharing PGx results with healthcare providers was limited at the six-month time point.
Authors
- Theresa V. Strong (ORCID: https://orcid.org/0000-0001-6783-8703)
- Yael Bar-Peled (ORCID: https://orcid.org/0000-0002-4904-5571)
- Jessica Johnson Denton (ORCID: https://orcid.org/0000-0002-4229-839X)
- Anna Carpenter Harris
- Caroline J. Vrana-Diaz
Institutions
- University of Alabama (US)
- University of Alabama at Birmingham (US)
- Baptist Cancer Center (US)
- Foundation for Prader-Willi Research (US)
Publication Details
- Journal
- Pharmacogenomics
- Published
- 2025-12-12
- DOI
- https://doi.org/10.1080/14622416.2026.2614280
- Primary Topic
- Genetic Syndromes and Imprinting
- Type
- article
- Field-Weighted Citation Impact
- 0.00